How 13 drugmakers have responded to the COVID-19 pandemic

Drugmakers have taken steps such as lowering insulin costs and waiving license restrictions on possible treatments in response to the COVID-19 pandemic. The companies have also cut staff and delayed mergers to protect themselves financially. Editor’s note: This is not an exhaustive list. Drugmakers are listed in alphabetical order. AbbVie waived license restrictions on an HIV drug […]

Coronavirus treatment: how to enroll in hydroxychloroquine study

The malaria drugs chloroquine and hydroxychloroquine have rapidly become top potential coronavirus treatments. But they lack any high-quality clinical evidence that shows they are effective against COVID-19. Dr. David Boulware, a University of Minnesota infectious disease professor, is running two experiments to test hydroxychloroquine in large controlled trials to determine the drug’s effectiveness. Both are now […]

LEADERSHIP TEAM

Nand Desai is dedicated to driving strategic transformations and integrations within the organization, leveraging his extensive experience across all functional groups to ensure successful execution. He holds a BBA from the University of Michigan – Ross School of Business. Before joining Rising, Nand was engaged in private equity at H.I.G. Capital, where he focused on middle-market opportunities. He began his career as an Analyst in the M&A group at Greenhill & Co., gaining valuable experience in financial analysis and advisory services.

Test Member

Test Menber

TEST MEMBER

Test Member

Nand Desai is dedicated to driving strategic transformations and integrations within the organization, leveraging his extensive experience across all functional groups to ensure successful execution. He holds a BBA from the University of Michigan – Ross School of Business. Before joining Rising, Nand was engaged in private equity at H.I.G. Capital, where he focused on middle-market opportunities. He began his career as an Analyst in the M&A group at Greenhill & Co., gaining valuable experience in financial analysis and advisory services.